Galena Biopharma (SLS)
(Delayed Data from NSDQ)
$1.21 USD
+0.02 (1.68%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $1.22 +0.01 (0.83%) 4:40 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 32% (80 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.38 | 9.99 |
Current Quarter Estimate | NA | 3.11 | 61.00 |
Year Ago Quarter Estimate | -0.33 | -4.81 | 54.84 |
Next Quarter Estimate | NA | 3.91 | 63.00 |
Next Year Estimate | -0.42 | 24.92 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 58.96 | 17.30 | 15.67 |
Next Year | 23.64 | 10.10 | 11.34 |
Last 5 Years | NA | 0.90 | 8.10 |
Next 5 Years | NA | 22.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -6.90 |
Price/Book (MRQ) | 23.59 | 2.05 |
Price/Cash Flow (MRFY) | NA | 16.44 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -154.18% |
Return on Equity (TTM) | -17,349.61% | -61.34% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.